Literature DB >> 32721529

Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.

Liubov Kozlovskaya1, Anastasia Piniaeva2, Georgy Ignatyev2, Alexey Selivanov2, Anna Shishova3, Anastasia Kovpak2, Ilya Gordeychuk3, Yury Ivin2, Anastasia Berestovskaya4, Egor Prokhortchouk5, Denis Protsenko4, Mikhail Rychev5, Aydar Ishmukhametov3.   

Abstract

OBJECTIVES: The outbreak of coronavirus disease 2019 (COVID-19) started in December 2019 in China and then spread worldwide over the following months, involving 188 countries. The objective of this study was to determine the molecular epidemiology of the COVID-19 outbreak in Russia.
METHODS: In this study, two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains were isolated and genetically characterized. A phylogenetic analysis of all available Russian sequences was then performed and these were compared to the epidemiological data on COVID-19 incidence to evaluate the molecular epidemiology and pattern of virus spread in the territory of Russia. RESULTS AND
CONCLUSIONS: Whole genome analysis of the isolates obtained in this study and 216 others isolated in Russia revealed a set of seven common mutations when compared to the original Wuhan virus, including amino acid substitutions in spike protein S and nucleoprotein N, possibly affecting their properties. Phylogenetic analysis of all Russian sequences and 8717 sequences from other countries showed multiple importations of the virus into Russia, local circulation, and several patterns of virus spread.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  COVID-19; Epidemiology; Mutation; Phylogenetic analysis; Russia; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32721529     DOI: 10.1016/j.ijid.2020.07.024

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  12 in total

1.  The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia.

Authors:  Galya V Klink; Ksenia R Safina; Elena Nabieva; Nikita Shvyrev; Sofya Garushyants; Evgeniia Alekseeva; Andrey B Komissarov; Daria M Danilenko; Andrei A Pochtovyi; Elizaveta V Divisenko; Lyudmila A Vasilchenko; Elena V Shidlovskaya; Nadezhda A Kuznetsova; Anna S Speranskaya; Andrei E Samoilov; Alexey D Neverov; Anfisa V Popova; Gennady G Fedonin; Vasiliy G Akimkin; Dmitry Lioznov; Vladimir A Gushchin; Vladimir Shchur; Georgii A Bazykin
Journal:  Virus Evol       Date:  2022-03-05

2.  Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography.

Authors:  Anastasia A Kovpak; Anastasia N Piniaeva; Oleg A Gerasimov; Irina O Tcelykh; Mayya Y Ermakova; Anna N Zyrina; Dmitry V Danilov; Yury Y Ivin; Liubov I Kozlovskaya; Aydar A Ishmukhametov
Journal:  Vaccines (Basel)       Date:  2022-06-15

3.  Structural characterization of β-propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles.

Authors:  Dmitry V Bagrov; Grigory S Glukhov; Andrey V Moiseenko; Maria G Karlova; Daniil S Litvinov; Petr А Zaitsev; Liubov I Kozlovskaya; Anna A Shishova; Anastasia A Kovpak; Yury Y Ivin; Anastasia N Piniaeva; Alexey S Oksanich; Viktor P Volok; Dmitry I Osolodkin; Aydar A Ishmukhametov; Alexey M Egorov; Konstantin V Shaitan; Mikhail P Kirpichnikov; Olga S Sokolova
Journal:  Microsc Res Tech       Date:  2021-09-09       Impact factor: 2.893

Review 4.  Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Pegah Mirzapour; Omid Dadras; Zahra Pashaei; Amirali Karimi; Mehrzad MohsseniPour; Mahdi Soleymanzadeh; Alireza Barzegary; Amir Masoud Afsahi; Farzin Vahedi; Ahmadreza Shamsabadi; Farzane Behnezhad; Solmaz Saeidi; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-06-08       Impact factor: 2.175

5.  Possible effects of air temperature on COVID-19 disease severity and transmission rates.

Authors:  Dominique Kang; Clifford Ellgen; Erik Kulstad
Journal:  J Med Virol       Date:  2021-05-03       Impact factor: 20.693

6.  Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro).

Authors:  Hussin A Rothan; Teow Chong Teoh
Journal:  Mol Biotechnol       Date:  2021-01-19       Impact factor: 2.695

7.  The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia.

Authors:  Galya V Klink; Ksenia Safina; Elena Nabieva; Nikita Shvyrev; Sofya Garushyants; Evgeniia Alekseeva; Andrey B Komissarov; Daria M Danilenko; Andrei A Pochtovyi; Elizaveta V Divisenko; Lyudmila A Vasilchenko; Elena V Shidlovskaya; Nadezhda A Kuznetsova; Andrei E Samoilov; Alexey D Neverov; Anfisa V Popova; Gennady G Fedonin; Vasiliy G Akimkin; Dmitry Lioznov; Vladimir A Gushchin; Vladimir Shchur; Georgii A Bazykin
Journal:  medRxiv       Date:  2021-12-05

8.  Reconstructing SARS-CoV-2 infection dynamics through the phylogenetic inference of unsampled sources of infection.

Authors:  Deshan Perera; Ben Perks; Michael Potemkin; Andy Liu; Paul M K Gordon; M John Gill; Quan Long; Guido van Marle
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

9.  High-Density Amplicon Sequencing Identifies Community Spread and Ongoing Evolution of SARS-CoV-2 in the Southern United States.

Authors:  Ryan P McNamara; Carolina Caro-Vegas; Justin T Landis; Razia Moorad; Linda J Pluta; Anthony B Eason; Cecilia Thompson; Aubrey Bailey; Femi Cleola S Villamor; Philip T Lange; Jason P Wong; Tischan Seltzer; Jedediah Seltzer; Yijun Zhou; Wolfgang Vahrson; Angelica Juarez; James O Meyo; Tiphaine Calabre; Grant Broussard; Ricardo Rivera-Soto; Danielle L Chappell; Ralph S Baric; Blossom Damania; Melissa B Miller; Dirk P Dittmer
Journal:  Cell Rep       Date:  2020-10-20       Impact factor: 9.423

10.  Identification of Hotspot Mutations in the N Gene of SARS-CoV-2 in Russian Clinical Samples That May Affect the Detection by Reverse Transcription-PCR.

Authors:  Sergei A Kiryanov; Tatiana A Levina; Maria V Konopleva; Anatoly P Suslov
Journal:  Diagnostics (Basel)       Date:  2022-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.